| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1137 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1026 | 2011 |
| Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ... The Lancet Neurology 7 (2), 129-135, 2008 | 792 | 2008 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 457 | 2010 |
| Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias VL Villemagne, K Ong, RS Mulligan, G Holl, S Pejoska, G Jones, ... Journal of Nuclear Medicine 52 (8), 1210-1217, 2011 | 408 | 2011 |
| Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease VL Villemagne, KE Pike, D Darby, P Maruff, G Savage, S Ng, ... Neuropsychologia 46 (6), 1688-1697, 2008 | 311 | 2008 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012 | 299 | 2012 |
| Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease S Ng, VL Villemagne, S Berlangieri, ST Lee, M Cherk, SJ Gong, ... Journal of nuclear medicine 48 (4), 547-552, 2007 | 293 | 2007 |
| The 18F-FDG PET cingulate island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies SM Lim, A Katsifis, VL Villemagne, R Best, G Jones, M Saling, J Bradshaw, ... Journal of Nuclear Medicine 50 (10), 1638-1645, 2009 | 282 | 2009 |
| Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 254 | 2013 |
| Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease VL Villemagne, RS Mulligan, S Pejoska, K Ong, G Jones, G O’Keefe, ... European journal of nuclear medicine and molecular imaging 39, 983-989, 2012 | 211 | 2012 |
| High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types VL Villemagne, S Ataka, T Mizuno, WS Brooks, Y Wada, M Kondo, ... Archives of neurology 66 (12), 1537-1544, 2009 | 210 | 2009 |
| Epilepsyecosystem. org: crowd-sourcing reproducible seizure prediction with long-term human intracranial EEG L Kuhlmann, P Karoly, DR Freestone, BH Brinkmann, A Temko, ... Brain 141 (9), 2619-2630, 2018 | 205 | 2018 |
| Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ... Neurology 78 (7), 477-484, 2012 | 205 | 2012 |
| Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia CC Rowe, S Pejoska, RS Mulligan, G Jones, JG Chan, S Svensson, ... Journal of Nuclear Medicine 54 (6), 880-886, 2013 | 198 | 2013 |
| Larger temporal volume in elderly with high versus low beta-amyloid deposition G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ... Brain 133 (11), 3349-3358, 2010 | 170 | 2010 |
| In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133 N Okamura, VL Villemagne, J Drago, S Pejoska, RK Dhamija, ... Journal of Nuclear Medicine 51 (2), 223-228, 2010 | 152 | 2010 |
| A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ... Molecular psychiatry 19 (4), 519-526, 2014 | 131 | 2014 |
| Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ... Brain 134 (3), 798-807, 2011 | 122 | 2011 |
| Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults YY Lim, KA Ellis, RH Pietrzak, D Ames, D Darby, K Harrington, RN Martins, ... Neurology 79 (16), 1645-1652, 2012 | 121 | 2012 |
